108 related articles for article (PubMed ID: 28836140)
1. Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.
Koshy M; Sher DJ; Spiotto M; Husain Z; Engelhard H; Slavin K; Nicholas MK; Weichselbaum RR; Rusthoven C
J Neurooncol; 2017 Dec; 135(3):529-534. PubMed ID: 28836140
[TBL] [Abstract][Full Text] [Related]
2. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
3. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
4. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
5. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
6. Disparities in glioblastoma survival by case volume: a nationwide observational study.
Raj R; Seppä K; Luostarinen T; Malila N; Seppälä M; Pitkäniemi J; Korja M
J Neurooncol; 2020 Apr; 147(2):361-370. PubMed ID: 32060840
[TBL] [Abstract][Full Text] [Related]
7. Survival trends in glioblastoma and association with treating facility volume.
Aulakh S; DeDeo MR; Free J; Rosenfeld SS; Quinones-Hinojosa A; Paulus A; Manna A; Manochakian R; Chanan-Khan AA; Ailawadhi S
J Clin Neurosci; 2019 Oct; 68():271-274. PubMed ID: 31133366
[TBL] [Abstract][Full Text] [Related]
8. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Lopez Ramos C; Brandel MG; Steinberg JA; Wali AR; Rennert RC; Santiago-Dieppa DR; Sarkar RR; Pannell JS; Murphy JD; Khalessi AA
J Neurooncol; 2019 Jan; 141(1):159-166. PubMed ID: 30460629
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care and outcomes for glioblastoma in patients with poor performance status.
Malakhov N; Lee A; Garay E; Becker DJ; Schreiber D
J Clin Neurosci; 2018 Jun; 52():66-70. PubMed ID: 29576419
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
[TBL] [Abstract][Full Text] [Related]
12. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
[TBL] [Abstract][Full Text] [Related]
13. No difference between lowest and highest volume hospitals in outcome after colorectal cancer surgery in the southern Netherlands.
van Erning FN; van Steenbergen LN; van den Broek WT; Rutten HJ; Lemmens VE
Eur J Surg Oncol; 2013 Nov; 39(11):1199-206. PubMed ID: 24044806
[TBL] [Abstract][Full Text] [Related]
14. Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Oct; 135(1):173-181. PubMed ID: 28687924
[TBL] [Abstract][Full Text] [Related]
15. The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation.
Grimm JC; Kilic A; Shah AS; Trent Magruder J; Valero V; Dungan SP; Russell SD; Tedford RJ; Whitman GJ; Sciortino CM
J Heart Lung Transplant; 2015 Nov; 34(11):1390-7. PubMed ID: 26296959
[TBL] [Abstract][Full Text] [Related]
16. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
Rhome R; Fisher R; Hormigo A; Parikh RR
J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
[TBL] [Abstract][Full Text] [Related]
17. Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
Osborn VW; Lee A; Garay E; Safdieh J; Schreiber D
Neurosurgery; 2018 Nov; 83(5):915-921. PubMed ID: 29092047
[TBL] [Abstract][Full Text] [Related]
18. The influence of hospital volume on long-term oncological outcome after rectal cancer surgery.
Jonker FHW; Hagemans JAW; Burger JWA; Verhoef C; Borstlap WAA; Tanis PJ;
Int J Colorectal Dis; 2017 Dec; 32(12):1741-1747. PubMed ID: 28884251
[TBL] [Abstract][Full Text] [Related]
19. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
20. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
Stupp R; Wong ET; Kanner AA; Steinberg D; Engelhard H; Heidecke V; Kirson ED; Taillibert S; Liebermann F; Dbalý V; Ram Z; Villano JL; Rainov N; Weinberg U; Schiff D; Kunschner L; Raizer J; Honnorat J; Sloan A; Malkin M; Landolfi JC; Payer F; Mehdorn M; Weil RJ; Pannullo SC; Westphal M; Smrcka M; Chin L; Kostron H; Hofer S; Bruce J; Cosgrove R; Paleologous N; Palti Y; Gutin PH
Eur J Cancer; 2012 Sep; 48(14):2192-202. PubMed ID: 22608262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
